Article
Plasma Caffeine Levels and Risk of Alzheimer's Disease and Parkinson's Disease: Mendelian Randomization Study.
Nutrients - 19 Apr 2022
Larsson Susanna C, Woolf Benjamin, Gill Dipender
Abstract excerpt
We leveraged genetic variants associated with caffeine metabolism in the two-sample Mendelian randomization framework to investigate the effect of plasma caffeine levels on the risk of Alzheimer's disease and Parkinson's disease. Genetic association estimates for the outcomes were obtained from the International Genomics of Alzheimer's Project, the International Parkinson's Disease Genomics consortium, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
